In the process of advancing the new medical reform program, there are many “obstructions†on key issues such as the reform of public hospitals. On February 23, the five departments issued the “Guiding Opinions on the Pilot Reform of Public Hospitalsâ€, which means that the new medical reform took three years. The program has made an important breakthrough in "execution power", and the new medical reform has made a breakthrough. Whether the relevant listed companies have "breakthroughs" in the corresponding strategies, the author has questioned the question.
The public hospital is called "public". In fact, it is not a real name. In fact, it is a "profit-making" hospital. The new regulations for the reform of public hospitals on the 23rd will throw away these "defects". The new regulations for public hospital reform refer to "taking medicine to raise medicine". This will return public hospitals to their own “public†and reflect their public welfare.
The reform of public hospitals involves a wide range of issues. There are nine reforms in the new regulations for public hospital reform, including the hospital's management system, compensation system, operational mechanism and supervision mechanism. The concern is that public hospitals gradually cancel the promotion of medical separation and reform. With the drug supplementation mechanism, the public hospital compensation will be changed from service channels, drug bonus income and government subsidies to service charges and government subsidies.
As an end market for pharmaceutical consumption, the reform of public hospitals is undoubtedly one of the important factors affecting the development of the pharmaceutical market, because the hospital is a carrier that connects medicines and equipment and thus “closely†links with relevant listed companies. The “reform†of public hospitals will bring about significant changes in three areas.
First, the new regulations for public hospital reform will cause major changes in the pharmaceutical market. The main changes are in two aspects: the elimination of drug additions in the reform of public hospitals will directly affect the pharmaceutical terminal consumer market, which will help curb the hospital's large prescriptions. The high-priced foreign drug market may be squeezed, and domestic similar drugs will be replaced by “spaceâ€. Domestic high-end pharmaceutical manufacturers will also face different levels of “restrictionsâ€. In the case of companies, high-end generic pharmaceutical companies with strong R&D capabilities and price advantages may face opportunities. Second, the sales volume of generic drugs will be corresponding. Increased, some hospitals that have tried the zero price difference of drugs show that the medical expenses have dropped by about 50%, while the income of primary medical institutions has also decreased by about 60%. The products are located in the grassroots market. Enterprises will benefit.
Secondly, according to the new regulations for public hospital reform, the hospitals of health and other departments and state-owned enterprises and institutions will carry out localized management reforms. The hospital will explore the establishment of various forms of public hospital corporate governance structure with the core of the board as the core, and implement the public The hospital has the status of an independent legal person, and has established a management system for the qualifications, selection and appointment of the president of a public hospital. The reform of the hospital management system will also profoundly affect the changes in the hospital procurement system, thus profoundly affecting the changes in the pharmaceutical logistics industry.
Some emerging industries will rise. For example, the reform of public hospitals will bring about changes in the pharmaceutical business. Some enterprises that survive the “happy†in drug add-on may face a crisis, but some pharmaceutical commercial enterprises that already have the basic conditions for integration are welcoming development opportunities and their development. The direction will be from regional monopoly to national layout, from endogenous growth to external mergers and acquisitions, forming a large-scale, channel-efficient logistics distribution network. In the past two years, some prophetic companies have begun to optimize and integrate internal resource allocation and improve operational efficiency. Now they are expanding and looking for cooperation with foreign commercial enterprises.
Third, the market will focus on large companies with brand and scale advantages. The new regulations for the reform of public hospitals will effectively "smooth" the disorderly competition of generic drugs. It is foreseeable that in the future, the government will strengthen supervision and encourage innovation, and the brand and the leading enterprises that take the lead in completing the industrial upgrading will benefit from the reform.
The new regulations for the reform of public hospitals may become the "baton" of the "production-distribution-consumption" of the products listed by the pharmaceutical companies. The profound changes brought about have just begun, and the opportunities and challenges will come to the fore. In the face of these opportunities and challenges, the relevant listed companies can only be “hands-on†if they act early, and they are willing to work hard.
disposable use of drainage tubes for medical purposes (silica gel) purpose: used for suction sealing wound, suitable for the drainage of blood and fluid during and after surgery. We have patent of drainage tubes for medical purposes for anti flow and anti leakage.
By discharging the air in the drainage bottle to form a negative pressure with the outside, the waste liquid at the other end of the drainage tube flows into the drainage bottle through the drainage tube to achieve the purpose of drainage.
T drinage tube, negative pressure drainage device , Catheter,drainage tube,drainage tubes for medical purposes, surgical drain, Surgical Latex T Drainage Tube T-Tube drain
Huali Technology Co., Ltd , https://www.jlhualitech.com